Overview

Role of Strontium Ranelate in Proximal Femur Fragility Fractures.

Status:
Recruiting
Trial end date:
2024-06-30
Target enrollment:
Participant gender:
Summary
This study is being conducted with the aim of comparing the time to bone healing after surgery for fragility fractures of proximal femur between patients receiving strontium ranelate and placebo. Patients recruited are of 60 years of age and above. Bone healing will be assessed on clinical parameters when patient is able to ambulate full weight bearing without pain and on Xray images using RUSH score. Moreover Dexa scan will be performed pre-operatively and at 3 months postoperatively. The findings of this study will help in setting up guidelines for treatment of fragility proximal femur fractures in our population as there is still paucity of literature on effectiveness of strontium ranelate from our part of the world.
Phase:
Phase 4
Details
Lead Sponsor:
Aga Khan University Hospital, Pakistan
Collaborator:
AO Trauma Middle East and North Africa
Treatments:
Strontium ranelate